There’s been a leap in potential new medicines being tested in clinical trials for Alzheimer’s, according to a new annual ...

We explain the science behind the headlines on dementia blood tests, what they are and who can benefit. And whether they can ...

The Dementia Community Champions play a key role in our mission to promote a better understanding of dementia and brain ...

Not everyone will experience difficulties with all of these activities and a person’s symptoms can progress at different rates. You can find information about how dementia commonly affects activities ...

A memory clinic is usually part of a hospital. The staff are specialists in finding out what is causing a person’s memory problems and diagnosing dementia. They will perform some in-depth tests and ...

Inheritance tax is paid from the estate of someone who has passed away, if their estate is above a certain threshold. However, a number of reliefs and exemptions are available. Currently, inheritance ...

If you already have a place in this event but would like to support Alzheimer’s Research UK, we’d love to have you on the team! There’s no minimum sponsorship target and we can provide help and ...

Join us on Monday 24 February 2025, for a day dedicated to supporting early career researchers in the dementia field. Sessions start at 11am. This event is designed to provide you with the knowledge, ...

Early and accurate diagnosis is the cornerstone of effective, person-centred care – and nowhere is this more important than in dementia. Spotting the signs early and getting a diagnosis can change ...

Find out about five major findings of dementia research over the years, including new treatments and potential ways of diagnosing dementia. Click on each box for more information. 1. The discovery of ...

Think Brain Health e-learning is an interactive online training tool designed to raise understanding of dementia and teach your employees about how improving brain health can reduce their risk of ...

Right now, there isn’t a cure for people with dementia. But hope is on the horizon with lecanemab and donanemab – the first Alzheimer’s treatments licensed in Britain that can slow down the disease, ...